Wouter Beumer

472 total citations
11 papers, 252 citations indexed

About

Wouter Beumer is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Wouter Beumer has authored 11 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Wouter Beumer's work include Cystic Fibrosis Research Advances (5 papers), Retinal Development and Disorders (3 papers) and Olfactory and Sensory Function Studies (2 papers). Wouter Beumer is often cited by papers focused on Cystic Fibrosis Research Advances (5 papers), Retinal Development and Disorders (3 papers) and Olfactory and Sensory Function Studies (2 papers). Wouter Beumer collaborates with scholars based in Netherlands, Germany and United Kingdom. Wouter Beumer's co-authors include Patricia Biasutto, Rob W.J. Collin, Kalyan Dulla, Michael E. Cheetham, Lonneke Duijkers, Peter Adamson, Anna Brugulat-Panés, Katarina Jovanović, Anthony Vugler and Mònica Aguilà and has published in prestigious journals such as PLoS ONE, Investigative Ophthalmology & Visual Science and JCI Insight.

In The Last Decade

Wouter Beumer

10 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wouter Beumer Netherlands	8	195	53	41	35	32	11	252
Anna Brugulat-Panés United Kingdom	6	273 1.4×	11 0.2×	51 1.2×	63 1.8×	51 1.6×	10	327
Wenjian Lv United States	5	401 2.1×	10 0.2×	130 3.2×	66 1.9×	18 0.6×	8	482
Aaron Black United States	5	209 1.1×	32 0.6×	83 2.0×	32 0.9×	107 3.3×	10	264
Lucas Fares‐Taie France	8	177 0.9×	13 0.2×	86 2.1×	16 0.5×	32 1.0×	15	238
Volker Paech Germany	10	76 0.4×	25 0.5×	10 0.2×	77 2.2×	7 0.2×	12	291
Efthymia Tsina Greece	7	196 1.0×	40 0.8×	21 0.5×	103 2.9×	139 4.3×	11	322
S. J. Lindauer United States	4	294 1.5×	11 0.2×	113 2.8×	66 1.9×	110 3.4×	6	320
Erin Hennessey United States	6	348 1.8×	13 0.2×	158 3.9×	16 0.5×	11 0.3×	9	402
Alfredo González United States	6	104 0.5×	11 0.2×	14 0.3×	11 0.3×	4 0.1×	12	204
Christine Zeschnigk Germany	7	128 0.7×	10 0.2×	56 1.4×	27 0.8×	7 0.2×	7	254

Countries citing papers authored by Wouter Beumer

Since Specialization

Citations

This map shows the geographic impact of Wouter Beumer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Beumer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Beumer more than expected).

Fields of papers citing papers by Wouter Beumer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter Beumer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Beumer. The network helps show where Wouter Beumer may publish in the future.

Co-authorship network of co-authors of Wouter Beumer

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter Beumer. A scholar is included among the top collaborators of Wouter Beumer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter Beumer. Wouter Beumer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Lee, Sang‐Eun, Kalyan Dulla, Wouter Beumer, et al.. (2023). Antisense oligonucleotide therapy corrects splicing in the common Stargardt disease type 1-causing variant ABCA4 c.5461-10T>C. Molecular Therapy — Nucleic Acids. 31. 674–688. 24 indexed citations

Kim, Hyeongju, Sophie Lenoir, Angela Helfricht, et al.. (2022). A pathogenic proteolysis–resistant huntingtin isoform induced by an antisense oligonucleotide maintains huntingtin function. JCI Insight. 7(17). 7 indexed citations

Leenaars, Cathalijn H. C., et al.. (2021). Animal models for cystic fibrosis: a systematic search and mapping review of the literature. Part 2: nongenetic models. Laboratory Animals. 55(4). 307–316. 6 indexed citations

Ritskes‐Hoitinga, Merel, et al.. (2020). Improving Translation by Identifying Evidence for More Human-Relevant Preclinical Strategies. Animals. 10(7). 1170–1170. 20 indexed citations

Beumer, Wouter, Jim Swildens, Teresinha Leal, et al.. (2019). Evaluation of eluforsen, a novel RNA oligonucleotide for restoration of CFTR function in in vitro and murine models of p.Phe508del cystic fibrosis. PLoS ONE. 14(6). e0219182–e0219182. 22 indexed citations

Dulla, Kalyan, Iris A. Schulkens, Wouter Beumer, et al.. (2019). QR-421a, an antisense oligonucleotide, for the treatment of retinitis pigmentosa due to USH2A exon 13 mutations. Investigative Ophthalmology & Visual Science. 60(9). 3250–3250. 8 indexed citations

Brinks, Vera, et al.. (2019). The Cystic Fibrosis-Like Airway Surface Layer Is not a Significant Barrier for Delivery of Eluforsen to Airway Epithelial Cells. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(5). 303–316. 16 indexed citations

Leenaars, Cathalijn H. C., et al.. (2019). Animal models for cystic fibrosis: A systematic search and mapping review of the literature – Part 1: genetic models. Laboratory Animals. 54(4). 330–340. 11 indexed citations

Dulla, Kalyan, Mònica Aguilà, Amelia Lane, et al.. (2018). Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models. Molecular Therapy — Nucleic Acids. 12. 730–740. 126 indexed citations

10.

Klein, Pontus, Lodewijk J.A. Toonen, Hyeongju Kim, et al.. (2018). I01 QRX-704, a novel antisense oligonucleotide therapy, designed to prevent hd pathology while maintaining htt function. A88.2–A88. 1 indexed citations

11.

Beumer, Wouter, Jim Swildens, Noreen Henig, et al.. (2015). WS01.2 QR-010, an RNA therapy, restores CFTR function using in vitro and in vivo models of ΔF508 CFTR. Journal of Cystic Fibrosis. 14. S1–S1. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact